Intellectual Property India Publishes Patent Application for 'Compositions And Methods For Reducing MHC Class I In A Cell' Filed by Intellia Therapeutics, Inc.

MUMBAI, India, Feb. 28 -- Intellectual Property India has published a patent application (202517003125 A) filed by Intellia Therapeutics, Inc., Cambridge, U.S.A., on Jan. 14, for 'compositions and methods for reducing mhc class i in a cell.'

Inventor(s) include Schultes, Birgit; Zhang, Yong; Zhang, Boning; Kilic, Ozgun; Balwani, Ishina; and Liu, Biao.

The application for the patent was published on Feb. 28, under issue no. 09/2025.

According to the abstract released by the Intellectual Property India: "Compositions and methods for reducing MHC class I protein expression in a cell comprising genetically modifying MHC class I for use e.g., in adoptive cell transfer therapies."

The patent application was internationally filed on June 15, 2...